Breathe Well Live Well
|
Aerospan improved pediatric asthma outcomes, regardless of prior therapy
Healio “The study findings indicate Aerospan is an effective treatment option for patients that require an inhaled steroid, such as those with mild to moderate asthma,” Karafilidis said. “This, coupled with our other data that suggest Aerospan did not … |
View full post on asthma – Google News
|
US FDA approves Acton Pharma's Aerospan to treat asthma
pharmabiz.com The Centres for Disease Control (CDC) estimates that more than 24 million Americans have asthma and of these, more than half have an asthma attack each year. Annually, the disease is responsible for nearly two million emergency room visits and accounts … |
View full post on asthma – Google News
|
Acton Says FDA Oks SNDA For AEROSPAN Inhalation Aerosol For Asthma
RTT News … has approved the sNDA (Supplemental New Drug Application) for AEROSPAN Inhalation Aerosol, a hydrofluoroalkane orally inhaled corticosteroid indicated for the maintenance treatment of asthma as a prophylactic therapy in adult and pediatric patients … |
View full post on asthma – Google News
|
Acton Pharma Says Trial Of Asthma Therapy Aerospan Shows No Growth Suppression
RTT News (RTTNews) – Privately-held Acton Pharmaceuticals Inc. Tuesday reported the publication of results of the Phase IIIb trial of Aerospan, a long-term asthma therapy, which said no suppression of growth and bone maturation was found in prepubescent … Acton Pharmaceuticals, Inc. Announces Publication of AEROSPAN(R) (Flunisolide … |
View full post on asthma – Google News